Top news of the week: 02.06.2021.
Startups
Biotech’s Relevancy Challenge In An Expanding Universe
The universe of public biotech companies has been growing for a decade, and increasingly so in the past few years as the IPO market has flourished. Hundreds of young aspiring biotechs have ...
How a protein 'Polaroid' led Amgen to finally crack the 'Achilles heel tumor' with Lumakras in 8 years
Two of Amgen’s R&D and clinical development experts gave Fierce Biotech a snapshot into the light-speed development process that brought Lumakras, formerly known as sotorasib, to the cusp ...
Good Day BIO: Startups, SAF tax credits, and Ron Swanson
If you thought D.C. would slow down ahead of Memorial Day, think again. Today, news on two bills that would streamline reporting requirements for Emerging Growth Companies and provide ...
Despite the ending of COVID restrictions, there’s no rush to schedule networking events and conventions
If you’re holding a cold beer at 5 p.m. and learning about social media marketing or how to raise money for your startup, chances are you’re still staring into a screen.
EFFECTOR Therapeutics bugs out of an IPO, taking the SPAC path with Locust Walk
EFFECTOR Therapeutics thinks it can be effective in clinical trial advancement following SPAC merger with Locust Walk
Genmab joins with Bolt to develop bispecific immune stimulators
Genmab and Bolt Biotherapeutics have teamed up to develop bispecific immune-stimulating antibody conjugates. The collaboration brings together Genmab’s bispecific capabilities with Bolt’s ...
Centessa raises $330M in third largest biotech IPO this year
The public offering follows just three months after Centessa, created from the merger of 10 Medicxi-backed drug startups, launched with $250 million in venture funding.
Amgen to Co-Develop Kyowa Kirin’s Atopic Dermatitis Candidate in Up-to-$1.2B Partnership
Amgen has agreed to co-develop and co-commercialize with Kyowa Kirin its Phase III-bound KHK4083, a potentially first-in-class treatment for atopic dermatitis, through a collaboration that ...